Merit Medical Systems Inc. operates as a rather sophisticated pit crew for the human body, specializing in the development, manufacture, and distribution of medical devices for interventional cardiology, radiology, and endoscopy. Essentially, they provide the tiny tools and intricate gadgets necessary for clinicians to perform minimally invasive procedures, often venturing into the body's most complex pathways. Their product portfolio is a veritable Swiss Army knife for internal exploration and repair, featuring everything from diagnostic and therapeutic catheters, guide wires, and inflation devices to stents and advanced breast care localization systems like the OneMark Detection Imaging System and SCOUT MD.

Operating within the high-stakes medical equipment industry, Merit Medical’s business model is primarily B2B, supplying hospitals, clinics, and other healthcare providers globally. With ten manufacturing facilities worldwide and a robust distribution network, they ensure their instruments are available for those critical moments when a patient's internal systems decide to throw a wrench in the works. The company prides itself on market leadership in specific niches, such as digital inflation technology and control syringes in the U.S., bolstered by an extensive patent portfolio boasting approximately 1,900 U.S. and international patents. This intellectual property acts as a formidable moat, protecting their innovations from less imaginative competitors. While they are the unsung heroes enabling doctors to fix our internal plumbing and wiring, the company isn't immune to the mundane realities of global supply chain challenges and intense competition, which always keep things "interesting" for investors.